US Patent 7994293 Antibodies specific for Dkk-1
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+349 characters)
Article
Patent abstract
Antibodies specific for Dkk-1, an inhibitor of the osteoanabolic Wnt/LRP5 signaling pathway, are described. The antibodies, which inhibit binding of Dkk-1 to LRP5, are useful in compositions for stimulating bone growth, in particular, compositions for treating bone disorders which result in a loss in bone, for example, osteoporosis.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07994293 Antibodies specific for Dkk-1 US Patent 7994293 Antibodies specific for Dkk-1
Infobox
Patent Number
0799429300
Patent Number
799429300
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
079942930
Date of Patent
August 9, 2011
0Patent Application Number
120128850
Date Filed
February 6, 2008
0Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
079942930
Date of Patent
August 9, 2011
0Patent Application Number
120128850
Date Filed
February 6, 2008
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07994293 Antibodies specific for Dkk-1
Infobox
Is a
Patent jurisdiction
Patent number
07994293
Date of patent
August 9, 2011
Patent application number
12012885
Date Filed
February 6, 2008
Patent primary examiner
Find more entities like US Patent 7994293 Antibodies specific for Dkk-1
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
